- 5.2Impact Factor
- 10.5CiteScore
- 16 daysTime to First Decision
Special Issues
Cells publishes Special Issues to create collections of papers on specific topics, with the aim of building a community of authors and readers to discuss the latest research and develop new ideas and research directions. Special Issues are led by Guest Editors, who are experts on the topic and all Special Issue submissions follow MDPI's standard editorial process.
The journal’s Editor-in-Chief and/or designated Editorial Board Member will oversee Guest Editor appointments and Special Issue proposals, checking their content for relevance and ensuring the suitability of the material for the journal. The papers published in a Special Issue will be collected and displayed on a dedicated page of the journal’s website. Further information on MDPI's Special Issue polices and Guest Editor responsibilities can be found here. For any inquiries related to a Special Issue, please contact the Editorial Office.
Molecular Mechanisms of Asthmatic Airway Inflammation
Deadline: 30 November 2026
Mechanisms of Immune Responses and Therapy
Deadline: 30 September 2026
Advances in Toxoplasma gondii Treatment, Immunology and Host–Parasite Interaction
Deadline: 31 July 2026
Emerging Insights into Natural Killer Cell Immunity in Infection and Cancer—2nd Edition
Deadline: 31 July 2026
Molecular Signatures and Cellular Pathways of Immune Dysfunction in HIV and Tuberculosis
Deadline: 31 July 2026
Mitochondria in Cancer Immune Evasion and Immunotherapy
Deadline: 30 July 2026
Targeted Therapy and Immunotherapy in Breast Cancer: Molecular Mechanisms and Translational Advances
Deadline: 30 July 2026
Harnessing the Immune System: Emerging Therapeutic Strategies in Cancer
Deadline: 25 July 2026
A New Frontier for Cancer Diagnosis and Therapy
Deadline: 25 July 2026
Ripening and Degradation Mechanisms of Neutrophil Extracellular Traps
Deadline: 10 July 2026
Hypoxia and the Immune Landscape in Infection and Cancer
Deadline: 10 July 2026
The Neuro-Immune Axis in Pulmonary Inflammation and Fibrosis
Deadline: 10 July 2026
of 14

